Eterna Therapeutics logo

Eterna Therapeutics Share Price (NASDAQ: ERNA)

$1.35

β–²

-0.03

(-2.17%)

Last updated on

Check the interactive Eterna Therapeutics Stock chart to analyse performance

Eterna Therapeutics stock performance

as on August 30, 2025 at 1:28 am IST

  • Today's Low:$1.35
    Today's High:$1.37

    Day's Volatility :1.46%

  • 52 Weeks Low:$1.35
    52 Weeks High:$28.65

    52 Weeks Volatility :95.29%

Eterna Therapeutics Stock Returns

PeriodEterna Therapeutics IncIndex (Russel 2000)
3 Months
-58.9%
0.0%
6 Months
-67.74%
0.0%
1 Year
-94.8%
0.0%
3 Years
255.26%
-4.7%

Eterna Therapeutics Inc Key Stats

Check Eterna Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.38
Open
$1.37
Today's High
$1.37
Today's Low
$1.35
Market Capitalization
$10.7M
Today's Volume
$38.5K
52 Week High
$28.65
52 Week Low
$1.35
Revenue TTM
$488.0K
EBITDA
$-11.7M
Earnings Per Share (EPS)
$-17.76
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-2264.31%

Stock Returns calculator for Eterna Therapeutics Stock including INR - Dollar returns

The Eterna Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

β‚Ή1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Eterna Therapeutics investment value today

Current value as on today

β‚Ή10,144

Returns

β‚Ή89,856

(-89.86%)

Returns from Eterna Therapeutics Stock

β‚Ή95,140 (-95.14%)

Dollar Returns*

β‚Ή5,284 (+5.28%)

Indian investors sentiment towards Eterna Therapeutics Stock

-29%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Eterna Therapeutics Stock from India on INDmoney has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Eterna Therapeutics Inc

  • Name

    Holdings %

  • Geode Capital Management, LLC

    0.26%

  • CI Private Wealth LLC

    0.23%

  • TWO SIGMA SECURITIES, LLC

    0.20%

  • Sippican Capital Adivsors

    0.13%

  • Cypress Point Wealth Management, LLC

    0.08%

  • JustInvest LLC

    0.06%

Analyst Recommendation on Eterna Therapeutics Stock

Rating
Trend

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Eterna Therapeutics(by analysts ranked 0 to 5 stars)

Eterna Therapeutics Share Price Target

What analysts predicted

Upside of 122.22%

Target:

$3.00

Current:

$1.35

Eterna Therapeutics share price target is $3.00, a slight Upside of 122.22% compared to current price of $1.35 as per analysts' prediction.

Eterna Therapeutics Stock Insights

  • Price Movement

    In the last 7 days, ERNA stock has moved down by -10.0%
  • ERNA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 165.0%
  • Price to Sales

    ForERNA every $1 of sales, investors are willing to pay $8.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Eterna Therapeutics Technicals Summary

Sell

Neutral

Buy

Eterna Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Eterna Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Eterna Therapeutics Inc logo
-21.97%
-67.74%
-94.8%
255.26%
-61.86%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Eterna Therapeutics Inc

Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-102, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Organization
Eterna Therapeutics
Employees
6
CEO
Mr. Sanjeev Luther
Industry
Healthcare

Key Management of Eterna Therapeutics Inc

NameTitle
Mr. Sanjeev Luther
CEO, President & Director
Ms. Sandra M. Gurrola
Principal Financial & Accounting Officer and Senior VP of Finance
Ms. Dorothy J. Clarke
General Counsel
Dr. Robert Hamilton Pierce M.D.
Chief Scientific Officer

Important FAQs about investing in ERNA Stock from India :

What is Eterna Therapeutics share price today?

Eterna Therapeutics share price today is $1.35 as on at the close of the market. Eterna Therapeutics share today touched a day high of $1.37 and a low of $1.35.

What is the 52 week high and 52 week low for Eterna Therapeutics share?

Eterna Therapeutics share touched a 52 week high of $28.65 and a 52 week low of $1.35. Eterna Therapeutics stock price today i.e. is closed at $1.35, lower by 95.29% versus the 52 week high.

How to invest in Eterna Therapeutics Stock (ERNA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Eterna Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Eterna Therapeutics Shares that will get you 1.1111 shares as per Eterna Therapeutics share price of $1.35 per share as on August 30, 2025 at 1:28 am IST.

What is the minimum amount required to buy Eterna Therapeutics Stock (ERNA) from India?

Indian investors can start investing in Eterna Therapeutics (ERNA) shares with as little as β‚Ή88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or β‚Ή882.86 in Eterna Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Eterna Therapeutics share’s latest price of $1.35 as on August 30, 2025 at 1:28 am IST, you will get 7.4074 shares of Eterna Therapeutics. Learn more about fractional shares .

What are the returns that Eterna Therapeutics has given to Indian investors in the last 5 years?

Eterna Therapeutics stock has given -61.86% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?